According to MRFR analysis, H. Pylori (Helicobacter Pylori) Test Market is expected to register
a CAGR of 5.2% during the forecast period of 2019 to 2025 and is expected to reach USD
2,924.2 Million by 2025. Helicobacter pylori infection occurs when the H. pylori bacteria infects
the stomach. Some of the major factors driving the market growth are the growing burden of H.
pylori infections and dyspepsia, availability of diagnostic tests, the presence of a cost-effective
diagnosis of H. pylori, and globally surging target patient population. Dyspepsia is a condition
associated with gastrointestinal (GI) disease, with a worldwide prevalence of around 20%. H.
pylori-associated diseases are commonly present with dyspepsia. On the contrary, low
diagnosis rates of helicobacter pylori infection in developing nations is anticipated to limit the
market growth during the review period.
Request Sample Copy:
The market has been divided by region into the Americas, Europe, Asia-Pacific, and the Middle
East & Africa. The H. pylori test market in the Americas has further been segmented into North
America and Latin America, with the North American market segregated into the US and
Canada. The existence of prominent market players and advanced healthcare infrastructure in
the US and Canada is assisting the dominance of the North American market. The European H.
pylori test market has been categorized as Western Europe and Eastern Europe. The Western
European market has further been classified as Germany, France, the UK, Italy, Spain, and the
rest of Western Europe. The H. pylori test market in Asia-Pacific has been segmented into
Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is likely to
register the fastest market growth during the forecast period owing to the presence of target
population base, growing awareness about H. pylori and its diagnosis, and increasing per ca